It is already being publicised - for those who say "why don't they publicise this"20 Aug 2025 16:00
Targeting is key, I would suggest an RNS is not going to be read by a single oncologist
*Neuro-Oncology Pediatrics* is a relatively new open-access journal launched by the Society for Neuro-Oncology (SNO) and the European Association of Neuro-Oncology (EANO). It serves the pediatric and adolescent/young adult (AYA) neuro-oncology community, focusing on basic and translational research, clinical trials, and late effects. As an open-access journal, its articles are freely available online to a global audience, which likely broadens its readership compared to subscription-based journals. The open-access charges are currently covered by SNO and EANO, making all content accessible without cost to readers, potentially increasing its reach.[](https://academic.oup.com/neuro-onc-peds)
The journal's readership primarily includes professionals in the pediatric neuro-oncology field, such as pediatric oncologists, neuro-oncologists, neurosurgeons, radiation oncologists, researchers, and other healthcare specialists like nurses and social workers. Given its affiliation with SNO and EANO, its audience likely includes members of these organizations, which are prominent in North America and Europe, respectively. Additionally, the journal’s global outlook suggests it attracts readers from institutions worldwide, particularly those involved in pediatric brain tumor research and treatment.[](https://academic.oup.com/neuro-onc-peds)
The journal’s open-access model and its backing by major neuro-oncology societies suggest a potentially wide readership within the niche but critical field of pediatric neuro-oncology.oncology/pages/why-publish-with-neuro-oncology)